RXST

RxSight, Inc. Common Stock
Data: 2026-01-30
$8.69
Price
-2.24%
Change
$34.71
52W High
$6.32
52W Low

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Quick Stats
Jan 30, 2026

57.0

AI Score

HOLD

4.83

Volume Ratio

Feb 24, 2026

Next Earnings

10

+ve Days (30d)

20

-ve Days (30d)

RXST Stock Summary

Last updated Jan 30, 2026

RXST is currently trading at $8.69, positioned below its 200-day moving average of $10.78, suggesting bearish momentum. The stock has a 52-week range of $6.32 to $34.71.

Technical Analysis: The 50-day moving average stands at $10.77, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 32.595, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.256, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RXST at 57.0/100 with a HOLD recommendation.

RXST (RxSight, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 32.595
CMF (20) -0.256
ROC (10) -11.236
ADX (14) 25.613
Indicator Value
MACD (12,26,9) -0.478
AROONOSC (14) -92.857
WILLAMS %R (14) -90.421
MFI (14) 33.146
RXST Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

RXST Price vs Max Options Open Interest
RXST Max Change In Options Open Interest

RXST Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RXST Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RXST Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RXST Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

RxSight, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

RXST Moving Averages Analysis

RXST (RxSight, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 9.43
20 9.64
30 10.25
50 10.77
100 9.84
200 10.78

RXST Fundamental Analysis

P/E (Forward) 116.2791
P/E (Trailing) --
Market Cap ($) 366.3 million
Earnings/Share ($) -0.88
Net Proft Margin (%) -0.2515
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.4623
EPS Estimate Next Year ($) -0.5076
WallStreet Target Price ($) 10.5
Most Recent Quarter